| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
HK:1177
Sino Biopharmaceutical
|
Jul 13, 2026 | BUY |
Strong Buy
+55.4% avg upside
7 analysts
|
$7.80
52.65% Upside
|
· |
|
HK:0241
Alibaba Health Information Technology
|
May 15, 2026 | SELL |
Buy
+54.4% avg upside
6 analysts
|
$4.20
27.23% Upside
|
· |
|
HK:1276
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H
|
Mar 25, 2026 | BUY |
Strong Buy
+92.0% avg upside
2 analysts
|
$92.00
57.80% Upside
|
· |
|
HK:1530
3SBio
|
Jan 13, 2026 | BUY |
Strong Buy
+69.5% avg upside
5 analysts
|
$38.00
118.60% Upside
|
· |
|
HK:6699
Angelalign Technology Inc.
|
Jan 07, 2026 | HOLD |
Buy
+13.7% avg upside
2 analysts
|
$75.00
2.35% Upside
|
· |
|
HK:2190
Zylox-Tonbridge Medical Technology Co., Ltd. Class H
|
Oct 09, 2025 | BUY |
Strong Buy
+43.1% avg upside
1 analyst
|
$28.00
43.15% Upside
|
· |
|
HK:0853
MicroPort Scientific
|
Sep 30, 2025 | HOLD |
Hold
+140.5% avg upside
2 analysts
|
$16.00
140.51% Upside
|
· |
|
HK:6078
Hygeia Healthcare Holdings Co., Ltd.
|
Aug 17, 2025 | BUY |
Strong Buy
+79.2% avg upside
2 analysts
|
$19.00
87.09% Upside
|
· |
|
HK:9860
ADICON Holdings Limited
|
Jun 04, 2025 | BUY |
Strong Buy
+122.2% avg upside
1 analyst
|
$8.60
122.21% Upside
|
· |
|
HK:9996
Peijia Medical Ltd.
|
Aug 26, 2024 | BUY |
Strong Buy
-3.8% avg upside
1 analyst
|
$4.00
3.80% Downside
|
· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.